Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.
2.

Further studies of the role of transforming growth factor-beta in human B cell function.

Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS.

J Immunol. 1989 Sep 15;143(6):1868-74.

PMID:
2550546
4.

Transforming growth factor-beta receptor profiles of human and murine embryonic palate mesenchymal cells.

Linask KK, D'Angelo M, Gehris AL, Greene RM.

Exp Cell Res. 1991 Jan;192(1):1-9.

PMID:
1845792
5.
7.
8.
9.

Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.

MacKay SL, Yaswen LR, Tarnuzzer RW, Moldawer LL, Bland KI, Copeland EM 3rd, Schultz GS.

Ann Surg. 1995 Jun;221(6):767-76; discussion 776-7.

11.
12.

Identification and partial characterization of TGF-beta 1 receptors on trabecular cells.

Borisuth NS, Tripathi BJ, Tripathi RC.

Invest Ophthalmol Vis Sci. 1992 Mar;33(3):596-603.

PMID:
1312071
13.

Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.

Kumar A, Rogers T, Maizel A, Sharma S.

J Immunol. 1991 Aug 1;147(3):998-1006.

PMID:
1713611
14.

Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.

Hall FL, Benya PD, Padilla SR, Carbonaro-Hall D, Williams R, Buckley S, Warburton D.

Biochem J. 1996 May 15;316 ( Pt 1):303-10.

16.

The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.

Moustakas A, Lin HY, Henis YI, Plamondon J, O'Connor-McCourt MD, Lodish HF.

J Biol Chem. 1993 Oct 25;268(30):22215-8.

19.
20.

Platelet factor 4 selectively inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor.

Whitson RH Jr, Wong WL, Itakura K.

J Cell Biochem. 1991 Sep;47(1):31-42.

PMID:
1658013

Supplemental Content

Support Center